Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NAUT
- Company Nautilus Biotechnology, Inc.
- Price $1.22
- Changes Percentage -15.86
- Change -0.23
- Day Low $1.21
- Day High $1.49
- Year High $2.92
- Year Low $0.62
- Market Cap $154,092,249
- Price Avg 50 EMA (D) $0.83
- Price Avg 200 EMA (D) $0.97
- Exchange NASDAQ
- Volume 801,095
- Average Volume 370,860
- Open $1.49
- Previous Close $1.45
- EPS -0.52
- PE -2.35
- Earnings Announcement 2025-10-28 12:30:00
- Shares Outstanding $126,305,122
Company brief: NAUTILUS BIOTECHNOLOGY, INC. (NAUT )
- Healthcare
- Biotechnology
- Mr. Sujal M. Patel
- https://www.nautilus.bio
- US
- N/A
- 08-07-2020
- US63909J1088
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
